Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Turning FDA's 'Clunky' Drug Database Into A Useable Goldmine

Executive Summary

The FDA's drug database, Drugs@FDA, is a goldmine of information. Unfortunately, because of the agency's "clunky" website, the data are difficult to access, search and aggregate, so the information's value is largely lost. But a group of scientists are using an $80,000 Open Science Prize to try to change that aggravating situation.


Related Content

US Capitol Capsule: Cancer Therapies, Orphan Drugs Dominated 2015 Approvals; PCSK9s Arrived
US Capitol Capsule: 2014: a year for orphan drugs, anti-PD-1s, 2nd chancers
2013 was springboard for 'breakthrough' drugs


Related Companies